The perinatal and maternal consequences of induction of labor at 39 weeks among low-risk nulliparous women are uncertain.
T h e ne w e ngl a nd jou r na l o f m e dicine R ecommendations regarding the timing of delivery are founded on a balancing of maternal and perinatal risks. Delivery before 39 weeks 0 days of gestation without medical indication is associated with worse perinatal outcomes than delivery at full term. 1 For women who are at 41 weeks of gestation or later, delivery has been recommended because of increasing perinatal risks. 2 When gestation is between 39 weeks 0 days and 40 weeks 6 days, common practice has been to avoid elective labor induction because of a lack of evidence of perinatal benefit and concern about a higher frequency of cesarean delivery and other possible adverse maternal outcomes, particularly among nulliparous women. 3 However, these conclusions were derived largely from observational studies in which labor induction was compared with spontaneous labor. [4] [5] [6] Such a comparison provides little insight into clinical management, because spontaneous labor is not a certain alternative to labor induction. Most observational studies that have used the clinically relevant comparator of expectant management have not shown a higher risk of adverse outcomes with labor induction; instead, some of these studies have shown that induction of labor resulted in a lower frequency of cesarean delivery and more favorable perinatal outcomes than expectant management. [7] [8] [9] [10] [11] A previous randomized trial conducted in the United Kingdom compared labor induction at 39 weeks of gestation with expectant management among 619 women who were 35 years of age or older and who had no other indication for delivery at 39 weeks of gestation. 12 The frequency of cesarean delivery was similar in the two groups (relative risk, 0.99; 95% confidence interval [CI] , 0.87 to 1.14), although several aspects of the trial, including a rate of operative vaginal delivery (i.e., vaginal delivery with the use of forceps or vacuum) of more than 30%, called into question the external validity of these results for the United States. The authors of that trial encouraged replication of their findings in other populations and the performance of a trial with a sample size sufficient "to test the effects of induction on . . . uncommon adverse neonatal outcomes." The ARRIVE trial (A Randomized Trial of Induction Versus Expectant Management) was designed to test the hypothesis that elective induction of labor at 39 weeks would result in a lower risk of a composite outcome of perinatal death or severe neonatal complications than expectant management among low-risk nulliparous women.
Me thods

Trial Oversight
We conducted this multicenter, randomized, controlled, parallel-group, unmasked trial at 41 hospitals participating in the Maternal-Fetal Medicine Units Network of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The protocol (available with the full text of this article at NEJM.org) was approved by the institutional review board at each hospital before participant enrollment. Written informed consent was obtained from all participants before randomization. An independent data and safety monitoring committee monitored the trial. The authors vouch for the accuracy and completeness of the data and for the fidelity of the trial to the protocol.
Screening and Recruitment
Low-risk nulliparous women who were at 34 weeks 0 days to 38 weeks 6 days of gestation with a live singleton fetus that was in a vertex presentation, who had no contraindication to vaginal delivery, and who had no cesarean delivery planned were screened for eligibility. Low risk was defined as the absence of any condition considered to be a maternal or fetal indication for delivery before 40 weeks 5 days (e.g., hypertensive disorders of pregnancy or suspected fetalgrowth restriction). Reliable information on the length of gestation was also a criterion for enrollment; information was considered to be reliable if the woman was certain of the date of her last menstrual period and that date was consistent with results of ultrasonography performed before 21 weeks 0 days or if the date of the last menstrual period was uncertain but results were available from ultrasonography performed before 14 weeks 0 days. Full eligibility criteria are provided in the Supplementary Appendix, available at NEJM.org.
Randomization and Management Strategy
Women who consented to participate were assessed again between 38 weeks 0 days and 38 weeks 6 days of gestation to ensure that they did not have new indications for delivery that would make them ineligible for the trial. Women who A Quick Take is available at NEJM.org
Labor Induction vs. Expectant Management were in labor or had premature rupture of membranes or vaginal bleeding at this time were considered to be ineligible. Women who met the inclusion criteria were randomly assigned in a 1:1 ratio to either labor induction or expectant management. The randomization sequence, prepared by an independent data coordinating center, used the simple urn method, with stratification according to clinical site. 13 The cervix was examined before labor, from 72 hours before to 24 hours after randomization, to assess dilation, effacement, and station of the fetus to determine a modified Bishop score (scores range from 0 to 12, with lower scores associated with a higher chance of cesarean delivery) (see the Supplementary Appendix).
14 Women in the induction group were assigned to undergo induction of labor at 39 weeks 0 days to 39 weeks 4 days. Women in the expectantmanagement group were asked to forego elective delivery before 40 weeks 5 days and to have delivery initiated no later than 42 weeks 2 days. A specific induction protocol was not mandated for women who underwent induction in either group. Other protocol guidelines are provided in the Supplementary Appendix.
Trained and certified research staff members abstracted information from medical records, including demographic information, medical history, and outcome data. Participants were followed up with an interview performed by research personnel immediately post partum. During this interview, women were asked to rate their labor pain on a 10-point Likert scale (with higher scores indicating greater pain) 15 and to rate their experiences on the Labor Agentry Scale, 16 which was designed to assess expectations and experiences of personal control during childbirth (scores range from 29 to 203, with higher scores indicating greater perceived control during childbirth). The score on the Labor Agentry Scale was also assessed in a second interview performed by research personnel 4 to 8 weeks after delivery.
Trial Outcomes
The primary outcome was a composite of perinatal death or severe neonatal complications and consisted of one or more of the following during the antepartum or intrapartum period or during the delivery hospitalization: perinatal death, the need for respiratory support within 72 hours after birth, Apgar score of 3 or less at 5 minutes, hypoxic-ischemic encephalopathy, 17 seizure, infection (confirmed sepsis or pneumonia), meconium aspiration syndrome, birth trauma (bone fracture, neurologic injury, or retinal hemorrhage), intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support. The principal prespecified maternal outcome (the main secondary outcome) was cesarean delivery. Prespecified subgroups for the primary perinatal outcome and for the secondary outcome of cesarean delivery were maternal race or ethnic group as reported by the participant (white, black, Asian, Hispanic, other, unknown, or more than one race), age of 35 years or older versus younger than 35 years, body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or more versus less than 30, and a modified Bishop score at the time of randomization of less than 5 versus 5 or higher. In addition, although it was not a baseline variable, the specialty of the admitting provider (obstetrics-gynecology, maternalfetal medicine, family practice, or midwifery) was prespecified for the subgroup analyses.
Neonatal secondary outcomes included birth weight, duration of respiratory support, cephalohematoma, shoulder dystocia, transfusion of blood products, hyperbilirubinemia requiring phototherapy or exchange transfusion, hypoglycemia requiring intravenous therapy, admission to the neonatal intermediate or intensive care unit, and length of hospitalization. In addition to cesarean delivery, other maternal secondary outcomes included hypertensive disorders of pregnancy (gestational hypertension or preeclampsia), indication for cesarean delivery, operative vaginal delivery, indication for operative vaginal delivery, uterine incisional extensions during cesarean delivery, chorioamnionitis, third-degree or fourthdegree perineal laceration, postpartum hemorrhage, postpartum infection, venous thromboembolism, number of hours in the labor and delivery unit, length of postpartum hospital stay, admission to the intensive care unit, and maternal death. Definitions of secondary outcomes are provided in the Supplementary Appendix.
Records of all infants who met the primary perinatal outcome were reviewed centrally to verify that the primary outcome had occurred. Records of infants in whom the primary outcome did not occur but that suggested (on the basis of a delivery hospitalization of 7 or more days or discharge to a long-term care facility) that clinically significant perinatal complications may have occurred were reviewed centrally as T h e ne w e ngl a nd jou r na l o f m e dicine well. Reviewers were unaware of the trial-group assignments.
Statistical Analysis
The expected rate of the primary perinatal outcome in the expectant-management group was estimated to be 3.5%. 18 We calculated that enrollment of 6000 women would provide a power of at least 85% to detect a 40% lower rate of the primary outcome in the induction group than in the expectant-management group, at a two-sided type I error rate of 5%. This power analysis incorporated the assumption that for 7.5% of the women, management would not be consistent with the protocol of the assigned strategy.
Analyses were performed according to the intention-to-treat principle. We compared continuous variables using the Wilcoxon signedrank test and categorical variables using the chi-square and Fisher's exact tests. A multinomial outcome was compared with the use of multinomial logistic regression. Time variables measured in days were categorized and compared with the Cochran-Armitage trend test. We used a group sequential method to control the type I error with the Lan-DeMets characterization of the O'Brien-Fleming boundary. One interim analysis was performed; in the final analysis of the primary outcome, a two-tailed P value of less than 0.046 was considered to indicate statistical significance. Because the adjustment is minimal, we report the 95% confidence interval for the relative risk. Our statistical analysis plan did not call for adjustment of P values to control for multiple comparisons of the results for the individual components of the primary outcome; therefore, these are reported as point estimates and 95% confidence intervals. For the secondary outcomes, the level of significance was adjusted post hoc for multiple comparisons with the false discovery rate method. 19 No method of imputation of missing data was used, although sensitivity analyses were performed in which data from participants who withdrew consent or were lost to follow-up were handled in various ways. To determine whether there was a differential effect of labor induction on the primary perinatal outcome and on the secondary outcome of cesarean delivery within the prespecified subgroups, we performed the Breslow-Day interaction test in which a P value of less than 0.05 was considered to indicate statistical significance.
The statistical analysis plan is provided in the protocol, available at NEJM.org.
R esult s
Characteristics of the Participants
From March 2014 through August 2017, a total of 50,581 women underwent screening for eligibility. Of the 22,533 eligible women, 6106 (27%) provided written informed consent and underwent randomization: 3062 were assigned to the induction group, and 3044 to the expectantmanagement group (Fig. 1) . At the time of randomization, 63% of the participants had an unfavorable modified Bishop score (i.e., a score <5). The two groups were similar at baseline, except that fewer women in the induction group than in the expectant-management group had had a previous pregnancy loss (22.8% vs. 25.6%, P = 0.01) ( Table 1 ). The obstetrical provider at the time of admission for delivery was a physician for 94% of women and a midwife for 6%.
Adherence
Three women in the induction group and 7 in the expectant-management group were lost to followup or withdrew consent. In the case of 184 women (6.0%) in the induction group and 140 (4.6%) in the expectant-management group, the management was not consistent with the protocol of the assigned strategy (details are provided in the Supplementary Appendix). Women in the induction group had a shorter median time from randomization to delivery than women in the expectant-management group ( 
Primary Outcome and Other Perinatal Outcomes
The primary perinatal outcome occurred in 4.3% of the neonates in the induction group and in 5.4% in the expectant-management group (relative risk, 0.80; 95% CI, 0.64 to 1.00; P = 0.049
Labor Induction vs. Expectant Management [P<0.046 indicated statistical significance for the primary perinatal outcome]) ( Table 2 ). This finding did not change after adjustment for previous pregnancy loss and was materially unchanged in the sensitivity analyses. Neonates in the induction group also had a shorter duration of respiratory support and of total hospital stay. Other secondary perinatal outcomes were similar in the two groups (see the Supplementary Appendix). Per-protocol delivery in the induction group was defined as electively induced labor from 39 weeks 0 days to 39 weeks 4 days or spontaneous labor or medically indicated delivery on or before 39 weeks 4 days (this also included delivery delayed past 39 weeks 4 days because of a new medical indication that had developed). Per-protocol delivery in the expectant-management group was defined as induction from 40 weeks 5 days to 42 weeks 2 days or spontaneous or medically indicated delivery on or before 42 weeks 2 days. * There were no significant differences between the groups except for previous pregnancy loss, which was less common in the induction group (P = 0.01). Percentages may not total 100 because of rounding. † Race or ethnic group was reported by the participant. ‡ Data are missing for 17 women (9 in the induction group and 8 in the expectant-management group). § Data are missing for 1 woman in the induction group. ¶ Data are missing for 1 woman in the expectant-management group. ‖ The body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. Data are missing for 30 women (13 in the induction group and 17 in the expectant-management group). ** Modified Bishop scores range from 0 to 12, with lower scores associated with a higher chance of cesarean delivery. Data are missing for 2 women in the expectant-management group. 
Maternal Outcomes
The percentage of women who underwent cesarean delivery was significantly lower in the induction group than in the expectant-management group (18.6% vs. 22.2%; relative risk, 0.84; 95% CI, 0.76 to 0.93; P<0.001) ( Table 3 ). This finding did not change materially after adjustment for previous pregnancy loss. Women assigned to induction of labor were also significantly less likely than women assigned to expectant management to have hypertensive disorders of pregnancy (9.1% vs. 14.1%; relative risk, 0.64; 95% CI, 0.56 to 0.74; P<0.001) and to have extensions of the uterine incision during cesarean delivery; in addition, women in the induction group reported less pain (i.e., had lower scores on the 10-point Likert scale) and more perceived control during childbirth (i.e., had higher scores on the Labor Agentry Scale). Although differences in scores were statistically significant, they were relatively small. Women in the induction group spent more time in the labor and delivery unit, but the length of their postpartum hospital stay was shorter (Table 3 ). Other secondary maternal health outcomes were similar in the two groups (see the Supplementary Appendix).
Subgroup Analyses
Prespecified baseline subgroup analyses of the primary perinatal outcome and of the secondary outcome of cesarean delivery showed no significant differences in results according to race or ethnic group, maternal age, body-mass index, or modified Bishop score (all P>0.05 by the BreslowDay test for homogeneity) (Fig. 2) . Subgroup analysis also revealed no significant betweengroup difference in the two outcomes according to type of admitting provider.
Discussion
In this randomized trial involving low-risk nulliparous women, we did not find a significant difference in the frequency of the primary outcome (a composite of adverse perinatal outcomes) between women randomly assigned to labor induction at 39 weeks of gestation and women assigned to expectant management. Nevertheless, * Details regarding the components of the primary perinatal outcome are provided in the Supplementary Appendix. † Exact confidence intervals are provided for rare outcomes. The widths of the confidence intervals for components of the primary outcome have not been adjusted for multiplicity, so they should not be used to infer definitive effects of the management strategies. ‡ We used a group sequential method to control the type I error with the Lan-DeMets characterization of the O'BrienFleming boundary. One interim analysis was performed; in the final analysis of the primary outcome, a two-tailed P value of less than 0.046 was considered to indicate statistical significance. Since the adjustment is minimal, we report the 95% confidence interval for the relative risk. The P values and 95% confidence intervals presented have not been adjusted for multiple comparisons of the secondary outcomes. ICU denotes intensive care unit, IQR interquartile range, and NA not applicable. † Data are missing for 4 women (1 in the induction group and 3 in the expectant-management group). ‡ The P value remained significant after controlling for multiple comparisons with the false discovery rate method. § The totals exclude 7 women who delivered before admission to the labor and delivery unit. Data are missing for 2 women (1 in each group). ¶ The variables were compared with the Cochran-Armitage trend test. ‖ Scores on the Labor Agentry Scale range from 29 to 203, with higher scores indicating greater perceived control during childbirth; included are women who had spontaneous labor, labor that started spontaneously but then was augmented, or induced labor. Data for 6 to 96 hours after delivery are missing for 288 women (127 in the induction group and 161 in the expectant-management group); data for 4 to 8 weeks after delivery are missing for 736 women (349 in the induction group and 387 in the expectant-management group). ** Labor pain was scored according to a 10-point Likert scale, with higher scores indicating greater pain; included are women who had spontaneous labor, labor that started spontaneously but then was augmented, or induced labor. Data on worst score are missing for 274 women (110 in the induction group and 164 in the expectant-management group); data on overall score are missing for 275 women (110 in the induction group and 165 in the expectant-management group). the relative risk was 20% lower in the induction group than in the expectant-management group, and the corresponding 95% confidence interval suggests that labor induction is probably not associated with a higher risk of adverse perinatal outcomes than expectant management, and it may be associated with as much as a 36% lower risk than expectant management. Labor induction also resulted in a significantly lower frequency of cesarean delivery and hypertensive The primary outcome was a composite of perinatal death or severe neonatal complications and consisted of one or more of the following during the antepartum or intrapartum period or during the delivery hospitalization: perinatal death, the need for respiratory support within the first 72 hours after birth, Apgar score of 3 or less at 5 minutes, hypoxic-ischemic encephalopathy, seizure, infection (confirmed sepsis or pneumonia), meconium aspiration syndrome, birth trauma (bone fracture, neurologic injury, or retinal hemorrhage), intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support. Race was reported by the participant; "other" race or ethnic group includes other, unknown, or more than one race or ethnic group. Modified Bishop scores range from 0 to 12, with lower scores associated with a higher chance of cesarean delivery. The body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. disorders of pregnancy than expectant management, even after post hoc adjustment for multiplicity. Our data suggest that 1 cesarean delivery may be avoided for every 28 deliveries among low-risk nulliparous women who plan to undergo elective induction of labor at 39 weeks. These findings contradict the conclusions of multiple observational studies that have suggested that labor induction is associated with an increased risk of adverse maternal and perinatal outcomes. [4] [5] [6] These studies, however, compared women who underwent labor induction with those who had spontaneous labor, which is not a comparison that is useful to guide clinical decision making. Conversely, our findings are consistent with observational studies, [7] [8] [9] [10] [11] [20] [21] [22] [23] as well as the randomized trial conducted by Walker et al., 12 in which women undergoing labor induction were compared with women undergoing the actual clinical alternative of expectant management.
B Cesarean Delivery
We found no significant difference in the magnitude of effect with respect to the primary perinatal outcome or cesarean delivery according to whether a woman had an unfavorable modified Bishop score at randomization. This finding may seem unexpected, given the consistent evidence that women with an unfavorable Bishop score have a higher chance of cesarean delivery when labor is induced than women with a favorable score. 3 As shown by the frequency of cesarean delivery among women with an unfavorable as opposed to a favorable baseline modified Bishop score (i.e., a score ≥5), this relationship holds true in our trial. Yet, because women with an unfavorable score at baseline also had a higher chance of cesarean delivery than women with a favorable score when they followed the expectant-management strategy, labor induction in women with an unfavorable score still resulted in fewer cesarean deliveries than expectant management.
This trial is larger than previous randomized trials that compared labor induction with expectant management in low-risk women, and as such it had the ability to detect differences that previous trials may not have discerned. Eligibility criteria ensured that only women with reliable information on length of gestation were included, and both women with favorable modified Bishop scores at baseline and those with unfavorable scores were enrolled.
Limitations of the trial should be noted. First, because masking was not feasible, ascertainment bias is possible. Second, despite its size, the trial was not powered to detect differences in infrequent outcomes, and most individual adverse perinatal outcomes were relatively uncommon. Third, it is unclear whether results are broadly generalizable; however, the inclusion of both university and community hospitals throughout the United States and of a variety of types of obstetrical providers, as well as the absence of a single protocol for induction or labor management, suggests that results are probably generalizable to similar centers. Finally, the cost-effectiveness of labor induction in low-risk nulliparous women at 39 weeks will need to be evaluated in further analyses.
In summary, we found that elective labor induction at 39 weeks of gestation did not result in a greater frequency of perinatal adverse outcomes than expectant management and resulted in fewer instances of cesarean delivery. These results suggest that policies aimed at the avoidance of elective labor induction among low-risk nulliparous women at 39 weeks of gestation are unlikely to reduce the rate of cesarean delivery on a population level; the trial provides information that can be incorporated into discussions that rely on principles of shared decision making. [24] [25] [26] [27] Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
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